Ascendis Pharma A/S
ASND
228.41
+2.36
+1.04%
Ascendis Pharma A/S
US · ASND
#1127 by market cap
Listed 2015
228.41
+2.36
+1.04%
Live - 5344 symbols - heartbeat 32s ago
· 2026-10-07 23:39
After-hours
228.41
0.00%
Overnight
229.84
+0.63%
- Market cap
- 15.03B
- P/E (TTM)i
- 18.23
- P/Bi
- 9.35
- EPSi
- -4.21
- Div yieldi
- 0.00%
- 52W posi
- 44%
Reader sentiment
Are you bullish or bearish on ASND?
Anonymous reader poll. Unscientific, not investment advice.
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.
- Founded
- 2006
- CEO
- Mr. Jan Moller Mikkelsen
- Employees
- 1,189
- Headquarters
- Hellerup, Capital Region, Denmark
- Fiscal year end
- 12-31
- Website
- ascendispharma.com
Company profile
- Exchange
- US
- Symbol
- ASND
- Market-cap rank
- #1127
- Listing date
- 2015-01-28
- Market cap
- 15.03B
- Float cap
- 15.02B
- Shares out
- 65.80M
- Float shares
- 65.77M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-07 23:39:45 · For reference only, not investment advice and not tailored to your situation.